Ticker
FHTXCompany Name
FOGHORN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -91.33M | -377.82% | $ 24.17M |
3/31/2025 | $ -95.86M | -407.85% | $ 23.5M |
12/31/2024 | $ -101.31M | -448.24% | $ 22.6M |
9/30/2024 | $ -103.89M | -407.18% | $ 25.52M |
6/30/2024 | $ -109.87M | -312.26% | $ 35.19M |
3/31/2024 | $ -116.96M | -345.06% | $ 33.9M |
12/31/2023 | $ -119.33M | -349.38% | $ 34.16M |
9/30/2023 | $ -120.94M | -371.34% | $ 32.57M |
6/30/2023 | $ -113.97M | -524.57% | $ 21.73M |
3/31/2023 | $ -110.7M | -536.94% | $ 20.62M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for FOGHORN THERAPEUTICS INC is calculated as follows: FCF [ $ -47.3M ] / Revenues [ $ 0 ]
(=) FCF % [ 0% ]
Minimum
Dec 31, 2020
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.85% |
median | 7.37% |
std | 19.48% |